Trials / Terminated
TerminatedNCT02475616
A Single Ascending Dose Study of PCO371 in Healthy Volunteers
A Randomized, Double-blind, Single Ascending Oral Dose Study To Evaluate Safety, Tolerability And Pharmacokinetics Of PCO371 In Healthy Volunteers
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- Chugai Pharmaceutical · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This is a single-center, placebo-controlled, randomized, double-blind, dose-escalation study to evaluate safety, tolerability, and PK of a single oral (PO) administration of PCO371 in healthy adult males. Caucasian and Japanese subjects will be randomized to receive either PCO371 or placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PCO371 | |
| DRUG | Placebo |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2015-10-01
- Completion
- 2015-10-01
- First posted
- 2015-06-19
- Last updated
- 2015-11-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02475616. Inclusion in this directory is not an endorsement.